We are live on ! Find out more
BGM

Burkehill Global Management Portfolio holdings

AUM $2.02B
1-Year Est. Return 85.32%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+85.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.52B
AUM Growth
-$242M
Cap. Flow
-$232M
Cap. Flow %
-15.26%
Top 10 Hldgs %
29.41%
Holding
211
New
70
Increased
9
Reduced
6
Closed
53

Top Buys

Rank Stock Value
1
ITT icon
ITT
ITT
+$62.7M
2
EL icon
Estee Lauder
EL
+$43.7M
3
ROL icon
Rollins
ROL
+$42.6M
4
MDLN
Medline Inc
MDLN
+$40.9M
5
O icon
Realty Income
O
+$34.7M

Top Sells

Rank Stock Value
1
SNDK
Sandisk
SNDK
+$89.8M
2
BRO icon
Brown & Brown
BRO
+$70.3M
3
LTM
LATAM Airlines Group S.A.
LTM
+$43M
4
VRSN icon
VeriSign
VRSN
+$42.1M
5
FOX icon
Fox Class B
FOX
+$30.6M

Sector Composition

Rank Sector Weight
1 Industrials 22.84%
2 Healthcare 18.52%
3 Financials 14.15%
4 Consumer Discretionary 12.53%
5 Technology 11.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MIR icon
51
Mirion Technologies
MIR
$3.91B
$8.2M 0.54%
350,000
BKV
52
BKV Corp
BKV
$2.68B
$8.14M 0.54%
+300,000
New +$7.53M
SLDE
53
Slide Insurance Holdings
SLDE
$2.47B
$7.79M 0.51%
400,000
SMA
54
SmartStop Self Storage REIT
SMA
$1.9B
$7.74M 0.51%
250,000
RAPP
55
Rapport Therapeutics
RAPP
$2.18B
$7.58M 0.5%
250,000
PRAX icon
56
Praxis Precision Medicines
PRAX
$10.1B
$7.37M 0.49%
+25,000
New +$4.66M
KLAR
57
Klarna Group
KLAR
$7.52B
$7.23M 0.48%
250,000
NUVL
58
DELISTED
Nuvalent
NUVL
$7.04M 0.46%
+70,000
New +$6.9M
ALHC icon
59
Alignment Healthcare
ALHC
$2.98B
$6.91M 0.46%
+350,000
New +$6.29M
NIQ
60
NIQ Global Intelligence PLC
NIQ
$3.45B
$6.6M 0.43%
400,000
TRVI icon
61
Trevi Therapeutics
TRVI
$2.64B
$6.57M 0.43%
525,000
BETA
62
Beta Technologies Inc
BETA
$5.43B
$6.35M 0.42%
+225,000
New +$6.72M
HPP
63
Hudson Pacific Properties
HPP
$779M
$6.19M 0.41%
571,428
-1
-0% -$15
INGM
64
Ingram Micro Holding
INGM
$6.55B
$6.08M 0.4%
285,000
MDU icon
65
MDU Resources
MDU
$4.32B
$5.86M 0.39%
+300,000
New +$5.9M
KYMR icon
66
Kymera Therapeutics
KYMR
$8.94B
$5.84M 0.38%
75,000
BHVN icon
67
Biohaven
BHVN
$2.21B
$5.64M 0.37%
+500,000
New +$6.19M
AHL
68
DELISTED
Aspen Insurance
AHL
$5.57M 0.37%
150,000
KEX icon
69
Kirby Corp
KEX
$6.93B
$5.51M 0.36%
50,000
MLYS icon
70
Mineralys Therapeutics
MLYS
$2.41B
$5.44M 0.36%
150,000
STC icon
71
Stewart Information Services
STC
$2.08B
$5.27M 0.35%
+75,000
New +$5.4M
VSEC icon
72
VSE Corp
VSEC
$6.12B
$5.18M 0.34%
+30,000
New +$5.13M
NAVN
73
Navan Inc
NAVN
$7.4B
$5.12M 0.34%
+300,000
New +$4.77M
NP
74
Neptune Insurance Holdings
NP
$4.39B
$5.03M 0.33%
+172,500
New +$4.54M
STUB
75
StubHub Holdings
STUB
$3.36B
$4.94M 0.33%
365,000

Similar funds

Burkehill Global Management's Q4 2025 Portfolio in Review

As of Q4 2025, Burkehill Global Management held 211 positions worth $1.52B, down 14% from $1.76B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Burkehill Global Management withdrew a net $232M in Q4 2025, closing 53 positions and reducing 6 holdings. Its most notable exit was Sandisk, an estimated $89.8M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Burkehill Global Management opened a new position in ITT worth $60.7M.

  • Burkehill Global Management's largest Q4 2025 buy was ITT: 350,000 shares worth $60.7M.
  • Burkehill Global Management added most to SoFi Technologies in Q4 2025, an estimated $27.9M increase.
  • Burkehill Global Management's biggest Q4 2025 reduction was CoreWeave, cutting an estimated $15.2M.
  • Burkehill Global Management fully exited Sandisk in Q4 2025, selling an estimated $89.8M.
  • Burkehill Global Management's ten largest holdings make up 29% of its $1.52B portfolio in Q4 2025.
  • Burkehill Global Management opened 70 new positions and closed 53 in Q4 2025.
  • Burkehill Global Management's portfolio value fell 14% quarter-over-quarter to $1.52B.

Based on Burkehill Global Management's 13F filing for Q4 2025, filed 17 Feb 2026.